Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 2Lymphoma, Non-Hodgkin 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neuroectodermal Tumors, Primitive, Peripheral 1Myelodysplastic Syndromes 1Lymphoma 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Hodgkin Disease 1Hematologic Diseases 1Graft vs Host Disease 1

Interventions

Etoposide 3trioctyl phosphine oxide 2indolepropanol phosphate 2Topotecan 2Melphalan 2Ifosfamide 2Cyclophosphamide 2Busulfan 2Whole-Body Irradiation 1Vincristine 1Transplantation 1Thiotepa 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiation 1Peripheral Blood Stem Cell Transplantation 1Pentetic Acid 1Minocycline 1Magnetic Resonance Spectroscopy 1Liquid Biopsy 1Heparin 1Granulocyte Colony-Stimulating Factor 1Glutamine 1Gelclair 1Filgrastim 1Electroacupuncture 1Doxorubicin 1Carmustine 1Carboplatin 1Bone Marrow Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Neuroectodermal Tumors, Primitive, Peripheral × Bone Marrow Transplantation × Clear all
NCT01795430 2015-01-09

Whole-Body Radiation Therapy, Systemic Chemotherapy, and High-Dose Chemotherapy Followed By Stem Cell Rescue in Treating Patients With Poor-Risk Ewing Sarcoma

City of Hope Medical Center

Phase NA Withdrawn

Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡